1.Residue depletion study and withdrawal period in milk for intramuscular gentamicin in dairy cows using LC-MS/MS
DoHui KIM ; Su Min NAM ; Hyoungjoon MOON ; Mi-Young PARK ; Hyun-Ok KU ; Hee YI ; Hwan Goo KANG
Journal of Veterinary Science 2025;26(6):e89-
Objective:
This study aimed to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantify gentamicin residues in milk and to establish a withdrawal period for an intramuscular gentamicin product in dairy cows.
Methods:
Nine Holstein cows received a gentamicin product (50 mg gentamicin sulfate/ mL) at 0.1 mL/kg twice daily at 12 h intervals via intramuscular injection. Milk samples were collected before dosing and at 12 h intervals up to 168 h after the final administration and analysed with a validated LC-MS/MS method using heptafluorobutyric acid as an ion-pairing reagent.
Results:
The method showed recovery rates of 86%–104%, coefficients of variation of 3%–11%, and limits of detection and quantitation of 23 and 70 ng/mL, respectively. Mean gentamicin concentrations exceeded the maximum residue limit (MRL; 0.2 mg/kg) at 12 h during treatment and 12 h after the final administration, and were < MRL in all cows from 36 h after the last dose. Based on residue depletion data and a national non-statistical guideline, a withdrawal period of 40–48 h was derived, and the regulatory withdrawal period for this product was established as 3 days.
Conclusions
and Relevance: The validated LC-MS/MS method enables rapid quantitation of gentamicin residues in bovine milk. A 3-day regulatory withdrawal period for this product supports milk safety, regulatory compliance, and practical use in dairy herds.
2.Influenza virus vaccine for neglected hosts: horses and dogs.
Woonsung NA ; Minjoo YEOM ; Huijoon YUK ; Hyoungjoon MOON ; Bokyu KANG ; Daesub SONG
Clinical and Experimental Vaccine Research 2016;5(2):117-124
This study provides information regarding vaccine research and the epidemiology of influenza virus in neglected hosts (horses and dogs). Equine influenza virus (EIV) causes a highly contagious disease in horses and other equids, and outbreaks have occurred worldwide. EIV has resulted in costly damage to the horse industry and has the ability of cross the host species barrier from horses to dogs. Canine influenza is a virus of equine or avian origin and infects companion animals that live in close contact with humans; this results in possible exposure to the seasonal epizootic influenza virus. There have been case reports of genetic reassortment between human and canine influenza viruses, which results in high virulence and the ability of transmission to ferrets. This emphasizes the need for vaccine research on neglected hosts to update knowledge on current strains and to advance technology for controlling influenza outbreaks for public health.
Animals
;
Disease Outbreaks
;
Dogs*
;
Epidemiology
;
Ferrets
;
Horses*
;
Humans
;
Influenza A virus
;
Influenza Vaccines
;
Influenza, Human*
;
Orthomyxoviridae*
;
Pets
;
Public Health
;
Seasons
;
Virulence
3.Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3.
Bo Kyu KANG ; Jeong Min HWANG ; Hyoungjoon MOON ; Sang Yoon HAN ; Jong Man KIM ; Dong Kun YANG ; Bong Kyun PARK ; Daesub SONG
Clinical and Experimental Vaccine Research 2016;5(1):26-30
PURPOSE: The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. MATERIALS AND METHODS: Blood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test. RESULTS: We found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test. CONCLUSION: There is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests.
Animals
;
Antibodies, Neutralizing
;
Asian Continental Ancestry Group*
;
Cross Reactions
;
Encephalitis Virus, Japanese*
;
Encephalitis, Japanese*
;
Genotype
;
Guinea Pigs
;
Hemagglutination
;
Horses
;
Humans
;
Immune Sera
;
Korea
;
Neutralization Tests
;
Seroepidemiologic Studies
4.Porcine epidemic diarrhea: a review of current epidemiology and available vaccines.
Daesub SONG ; Hyoungjoon MOON ; Bokyu KANG
Clinical and Experimental Vaccine Research 2015;4(2):166-176
Porcine epidemic diarrhea virus (PEDV), an Alphacoronavirus in the family Coronaviridae, causes acute diarrhea, vomiting, dehydration, and high mortality rates in neonatal piglets. PEDV can also cause diarrhea, agalactia, and abnormal reproductive cycles in pregnant sows. Although PEDV was first identified in Europe, it has resulted in significant economic losses in many Asian swine-raising countries, including Korea, China, Japan, Vietnam, and the Philippines. However, from April 2013 to the present, major outbreaks of PEDV have been reported in the United States, Canada, and Mexico. Moreover, intercontinental transmission of PEDV has increased mortality rates in seronegative neonatal piglets, resulting in 10% loss of the US pig population. The emergence and re-emergence of PEDV indicates that the virus is able to evade current vaccine strategies. Continuous emergence of multiple mutant strains from several regions has aggravated porcine epidemic diarrhea endemic conditions and highlighted the need for new vaccines based on the current circulating PEDV. Epidemic PEDV strains tend to be more pathogenic and cause increased death in pigs, thereby causing substantial financial losses for swine producers. In this review, we described the epidemiology of PEDV in several countries and present molecular characterization of current strains. We also discuss PEDV vaccines and related issues.
Asian Continental Ancestry Group
;
Canada
;
China
;
Coronaviridae
;
Dehydration
;
Diarrhea*
;
Disease Outbreaks
;
Epidemiology*
;
Europe
;
Genetics
;
Humans
;
Japan
;
Korea
;
Mexico
;
Mortality
;
Philippines
;
Porcine epidemic diarrhea virus
;
Swine
;
United States
;
Vaccines*
;
Vietnam
;
Vomiting
5.Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs.
Minki HONG ; Bokyu KANG ; Woonsung NA ; Dongjun AN ; Hyoungjoon MOON ; Doo Jin KIM ; Jinsik OH ; Seong Jun PARK ; Haryoung POO ; Jeong Ki KIM ; Jongman KIM ; Daesub SONG
Clinical and Experimental Vaccine Research 2013;2(1):66-68
PURPOSE: The avian origin canine influenza virus H3N2 has been recently isolated and found to be currently in dog population in South Korea and China. The purpose of this study was to clarify the relationship between immunosuppressive glucocorticoids used in veterinary clinical practice and viral shedding pattern of influenza in dogs. MATERIALS AND METHODS: Eight conventional beagle dogs were divided into control infection group and immunocompromised group. Dogs of both groups were infected with H3N2 canine influenza virus (2x106.0 EID50/0.1 mL). Dogs in immunocompromised group were given orally 3.0 mg/kg prednisolone for 7 days. Virus shedding was monitored using real-time polymerase chain reaction. After necropsy, histopathologic lesions were compared. RESULTS: We found that immunocompromised dogs exhibited more prolonged (8 days vs. 13 days) and higher magnitude viral shedding than control group (peak titer of viral shedding 4.6 vs. 5.5 EID50). CONCLUSION: Restricted use of immunosuppressive drugs in the clinical setting might help control the rapid spread of H3N2 through local dog populations.
Animals
;
China
;
Dogs
;
Glucocorticoids
;
Immunosuppression
;
Influenza A Virus, H3N2 Subtype
;
Influenza, Human
;
Orthomyxoviridae
;
Prednisolone
;
Real-Time Polymerase Chain Reaction
;
Republic of Korea
;
Viral Load
;
Virus Shedding

Result Analysis
Print
Save
E-mail